Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.

Andrsova I, Valaskova I, Kubus P, Vit P, Gaillyova R, Kadlecova J, Manouskova L, Novotny T.

Pacing Clin Electrophysiol. 2012 Jul;35(7):798-803. doi: 10.1111/j.1540-8159.2012.03399.x. Epub 2012 Apr 22.

PMID:
22519458
2.

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.

van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IM, Alings AM, Bosker HA, Bracke FA, van den Heuvel F, Waalewijn RA, Bikker H, van Tintelen JP, Bhuiyan ZA, van den Berg MP, Wilde AA.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):748-56. doi: 10.1161/CIRCEP.112.970517. Epub 2012 Jul 10.

3.

Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Jiang D, Jones PP, Davis DR, Gow R, Green MS, Birnie DH, Chen SR, Gollob MH.

Channels (Austin). 2010 Jul-Aug;4(4):302-10. Epub 2010 Jul 14.

4.

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A.

Circulation. 2002 Jul 2;106(1):69-74.

5.

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Laitinen-Forsblom P, Lahtinen AM, Viitasalo M, Toivonen L, Kontula K, Swan H.

BMC Med Genet. 2009 Feb 12;10:12. doi: 10.1186/1471-2350-10-12.

6.

A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.

Roston TM, Guo W, Krahn AD, Wang R, Van Petegem F, Sanatani S, Chen SR, Lehman A.

J Electrocardiol. 2017 Mar - Apr;50(2):227-233. doi: 10.1016/j.jelectrocard.2016.09.006. Epub 2016 Sep 8.

PMID:
27646203
7.

Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.

Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, Makita N, Horie M.

Europace. 2014 Nov;16(11):1646-54. doi: 10.1093/europace/eut382. Epub 2014 Jan 6.

PMID:
24394973
8.

Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.

Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, Hasegawa K, Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M.

Circ J. 2013;77(7):1705-13. Epub 2013 Apr 18.

9.

Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.

Laitinen PJ, Swan H, Piippo K, Viitasalo M, Toivonen L, Kontula K.

Ann Med. 2004;36 Suppl 1:81-6. Review.

PMID:
15176428
10.

[Catecholaminergic polymorphic ventricular tachycardia].

Leren IS, Haugaa KH, Edvardsen T, Anfinsen OG, Kongsgård E, Berge KE, Leren TP, Amlie JP.

Tidsskr Nor Laegeforen. 2010 Jan 28;130(2):139-42. doi: 10.4045/tidsskr.09.0529. Review. Norwegian.

11.

Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Hiippala A, Arrhenius B, Lahtinen AM, Kontula K, Toivonen L, Happonen JM, Swan H.

J Cardiovasc Electrophysiol. 2012 Feb;23(2):194-9. doi: 10.1111/j.1540-8167.2011.02188.x. Epub 2011 Sep 28.

PMID:
21954897
12.

A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.

de la Fuente S, Van Langen IM, Postma AV, Bikker H, Meijer A.

Pacing Clin Electrophysiol. 2008 Jul;31(7):916-9. doi: 10.1111/j.1540-8159.2008.01111.x.

PMID:
18684293
13.

Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.

Garabedian L, Verryckt A, Panzer J, De Wolf D.

Acta Paediatr. 2008 Jan;97(1):127-9. Epub 2007 Dec 3.

PMID:
18052993
14.

Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Pflaumer A, Davis AM.

Heart Lung Circ. 2012 Feb;21(2):96-100. doi: 10.1016/j.hlc.2011.10.008. Epub 2011 Nov 25. Review.

PMID:
22119737
16.

Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.

Heiner JD, Bullard-Berent JH, Inbar S.

Pediatr Emerg Care. 2011 Nov;27(11):1065-8. doi: 10.1097/PEC.0b013e3182360606.

PMID:
22068070
17.

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.

J Med Genet. 2005 Nov;42(11):863-70.

18.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

PMID:
21315846
19.

Catecholaminergic polymorphic ventricular tachycardia.

Liu N, Ruan Y, Priori SG.

Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):23-30. doi: 10.1016/j.pcad.2007.10.005. Review.

PMID:
18634915
20.

Genetic characterization of familial CPVT after 30 years.

Beery TA, Shah MJ, Benson DW.

Biol Res Nurs. 2009 Jul;11(1):66-72. doi: 10.1177/1099800409333369. Epub 2009 Apr 26.

PMID:
19398417

Supplemental Content

Support Center